Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00785512 · ClinicalTrials.gov registry record · Phase 4
A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy
A Phase 4 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 207
- Enrollment target
NCT00785512 is a Phase 4 study that has completed, run by Forest Laboratories. The registered enrollment target is 207 participants.
The verdict
NCT00785512, a Phase 4 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 207 participants
- Enrollment target
Study Summary
This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.
Interventions
- DRUG Placebo
- DRUG Nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2008-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00785512
The ClinicalTrials.gov registry entry for NCT00785512 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00785512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00785512 about?
NCT00785512 is a clinical study titled "A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy". This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.
What is the current status of trial NCT00785512?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 207 participants. The study started on 2008-11.
What interventions are being tested in trial NCT00785512?
The interventions under investigation include: Placebo (DRUG), Nebivolol (DRUG).
Who is sponsoring clinical trial NCT00785512?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.